Estrella Immunopharma Warrant
ESLAW
ESLAW
12 hedge funds and large institutions have $208K invested in Estrella Immunopharma Warrant in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
12
Holding in Top 10
–
Calls
$1K
Puts
–
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $182K |
|
|||
|
ASM
2
ATW SPAC Management
New York
| $7.59K |
|
|||
3
D.E. Shaw & Co
New York
| $3.81K |
|
|||
4
Walleye Trading
New York
| $3.46K |
|
|||
|
SIA
5
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $3K |
|
|||
|
YCM
6
Yakira Capital Management
Westport,
Connecticut
| $2.21K |
|
|||
|
WA
7
Whitebox Advisors
Minneapolis,
Minnesota
| $2.01K |
|
|||
8
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1.7K |
|
|||
|
CS
9
Clear Street
New York
| $1.61K |
|
|||
|
LCM
10
Landscape Capital Management
Englewood,
New Jersey
| $650 |
|
|||
|
WAM
11
Wolverine Asset Management
Chicago,
Illinois
| $104 |
|
|||
12
UBS Group
Zurich,
Switzerland
| $47 |
|
|||
|
HCM
13
Highbridge Capital Management
New York
| – |
|